USANA Health Sciences, Inc.
USANA Health Sciences, Inc. (USNA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
usna · stock forecast · 8 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Hold
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$35.00
Consensus
$35.00
+91.4% upside
Low
$35.00
Median: $35 · Last Close: $18.29
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $18.22 | ↓ 0.40% |
1-day model range: $18.12–$18.31. Peak: $18.31 (-0.40%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $13 | -30.5% |
| 2028 | $11 | -42.2% |
| 2029 | $10 | -47.6% |
| 2030 | $9 | -50.2% |
| 2031 | — | -51.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · USNA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-02-27 | DA Davidson | Maintains | Neutral→Neutral |
| 2025-01-02 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-10-23 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-07-25 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-05-07 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-02-22 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-10-25 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-04-26 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-02-13 | DA Davidson | Maintains | Neutral→Neutral |
| 2022-10-27 | DA Davidson | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on USANA Health Sciences, Inc. (USNA) stock. Of the recent 40 rating actions, 5 were upgrades and 10 were downgrades. 8 analysts currently cover USNA.
Analyst Recommendation Trends
USNA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$875M
↓ 5.4% YoY
Revenue Next Year
$850M
↓ 2.9% YoY
EPS This Year
$2.87
EPS Next Year
$2.45
↓ 14.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast USNA EPS of $2.87 for the current fiscal year, based on estimates from 1 analysts. The USNA revenue forecast is $875M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The USNA stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus USNA price target is $35.00 (+91.4% upside), with an analyst consensus of Hold.
The USNA short-term stock prediction for tomorrow is $18.22 (-0.40%). The USNA stock price prediction for 2027 estimates an average of $13. The USNA stock prediction for 2030 projects a range of $9–$10.
USANA Health Sciences, Inc. trades on NYSE under the ticker USNA. The USNA stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 25% of covering analysts.
Frequently asked questions
USNA forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month USNA price target is $35.00, with a high forecast of $35.00 and a low of $35.00. The median price target is shown in the chart above when available. This implies +91.4% potential upside from the current price of $18.29.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.